Tau protein as architect: why the mutant form wrecks the brain before old age ✎ bioRxiv

Original: "A conserved serotonin receptor pathway is a druggable modifier of Tau pathology, neural circuit formation and neurodegeneration"
b42w:2608.90041 · the paper's page · 2026-08-27 · CC BY-ND 4.0 · independent analysis · 3 min
The mutant tau protein P301L disrupts neural connections in the fruit fly brain already during development, and the process can be halted by blocking the serotonin receptor 5-HT7.

Construction is in full swing: neurons are laying down their processes the way bricklayers stack up walls. But an error has crept into the blueprints. The protein tau, which normally serves as scaffolding for the cellular framework, in its mutant form starts dictating the wrong dimensions. In the fruit fly brain, where human tau with the P301L mutation is active from birth, the building comes out crooked before any tenants even move in.

Tauopathies used to be seen as diseases of the mature brain: the protein accumulates, neurons die, dementia sets in. But the new work on fruit flies shows that mutant tau P301L strikes the developing brain separately from its role in degeneration. In flies expressing this protein from the moment they hatch, the axons of Kenyon cells fail to form the normal lobes of the mushroom bodies, the centers of learning and memory. When expression was switched on only in adulthood, no defect appeared. So the protein is breaking the construction phase itself.

The fruit fly mushroom bodies are named for their resemblance to a mushroom cap. They consist of just a few thousand neurons, yet they govern complex behavior, including learning and memory. In flies with mutant tau these structures can be missing entirely, even though the neurons themselves stay alive.

But there is good news too: construction defects can be fixed. The scientists blocked the serotonin receptor 5-HT7, a molecular foreman's whistle that relays signals inside the cell. Genetic or pharmacological suppression of this receptor saved the flies from behavioral and structural defects and also reduced the accumulation of pathological forms of tau. Flies with the mutant protein that received the blockade lived longer, slept better, and climbed upward almost like healthy ones.

Anchor number: by day 30 of life, the climbing ability of flies with P301L had dropped by 70%. It is as if a construction worker who used to reach the tenth floor in a minute could now, in the same time, make it only to the third.

The work changes how we think about when the disease begins. Early signals used to be sought in the adult brain, but now it is clear that the window for intervention opens long before symptoms appear, at the stage when neural circuits are only being laid down. The fruit fly model allows rapid testing of drugs and modifier genes. In the future it will be possible to study in detail which signaling pathways the 5-HT7 receptor activates in neurons and to find more specific targets. And also to check whether the protective effect holds in mice with tauopathy.

Building a brain is not a one-time event but a process that continues throughout life. An error in the blueprints made at the start may only show up decades later. But if it is found and fixed in time, the building will stand.

The mushroom bodies of Drosophila are named for their resemblance to a mushroom cap. They consist of just a few thousand neurons, yet they govern complex behavior, including learning and memory. In flies with mutant tau, these structures can be missing entirely, even though the neurons themselves stay alive.

The idea that neurodegeneration begins long before symptoms echoes Daniel Keyes's novel Flowers for Algernon, where the protagonist's intellectual decline is portrayed as the gradual unraveling of neural connections that were once formed.

Take the whole work

Not published on arXiv. Here are its page, the PDF and the formalization: you can check it yourself, not only read our account.

Concepts
tau protein therapy receptor drug target parkinsons disease promoter Post-transcriptional regulation transcription factor neurotransmitter telomere dna repair solubility